More than a decade into its existence, the current size and sweeping future ambitions of the insect-protein manufacturer has prompted a change in leadership. Krishnamoorthy joins a company that has research centers in France and the Netherlands and operates production sites in France and the U.S. The company has broader goals for new sites on every continent.###“Ynsect is on the cusp of transitioning from a late-stage startup to a commeris zinc gluconate good for acnecially viable company scaling up to meet its strategic objectives”, Hans Wackwitzsolaray cal mag, a board member at Ynsect, said in a statement. “Shankar has a proven track record as a CEO leading sustained, profitable growth in the competitferrous fumarate and folic acid tablet ki kaj koreive and challenging energy sector.”###Ynsect said last year it plans to start building a large-scale farm in the U.S later in 2023. iron tablets starting with fIt first established a presence in the U.S. in March of 2022, adding Nebraska mealworm company Jord Producers to its portfolio. In April, Ynsect closed a $175 million funding round to fund its expansion and prioritize higher-value foodferrocite 324mg for pets and humans. Bloomberg estimated the company has raised about $625 million so far.